Protocol Number:
AALL08B1
Study Name:
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
AALL0932
Study Name:
Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
AALL1131
Study Name:
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Testing Clofarabine (IND#73789, NSC#606869) in the Very High Risk Stratum
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
AALL1231
Study Name:
A Phase III Randomized Trial Investigating Bortezomib (NSC#681239; IND#58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) aAd TÂ Lymphoblastic Lymphoma (T-LLy)
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
Study Name:
Risk-Stratified Randomized PhaseIII Testing of Blinatumomab (IND#117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
AAMLOSB1
Study Name:
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (OS)
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
AAML1031
Study Name:
A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC#681239, NSC#724772) for Patients with High Allelic Ratio FLT3/ITD
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
AAML1331
Study Name:
A Phase III Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide and All-Trans Retinoic Acid
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
AAML1531
Study Name:
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Age Group:
Pediatrics
Background Information:
See full details
Protocol Number:
ACCL0933
Study Name:
(STUDY CLOSED) A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Age Group:
Pediatrics
Background Information:
See full details